BioSpace News Archive

Alithya Group inc. (TSX: ALYA) (NASDAQ: ALYA) (“Alithya”), a leader in digital strategy and technologies employing more than 2,000 highly qualified professionals offering enterprise solutions across Canada, the United States, and Europe, is proud to announce the acquisition of Travercent LLC, (“Travercent ").

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has experienced a recent surge in its E-Commerce revenue as well as the number of individual orders.

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that Akorn and certain of its lenders have reached an agreement that extends the standstill period to February 7, 2020.

Millar, Inc., a leading manufacturer and OEM solutions provider of sensor-based devices for clinical and life science applications, is pleased to celebrate an ongoing and successful strategic worldwide partnership with ADInstruments, an industry leader of data acquisition systems.

Medtronic plc (NYSE:MDT) and ChristianaCare today announced a collaboration designed to improve outcomes for ChristianaCare patients in Delaware and the surrounding region.

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating narcolepsy, announced today that the U.S. Food and Drug Administration (FDA) has approved NouressTM (AV001), a cysteine hydrochloride injection, a critical drug for treating neonatal patients requiring total parenteral nutrition (TPN).

Calmer Canine™ from Assisi Animal Health is Drug-Free Solution to Problem That Plagues 1 in 7 Dogs in the U.S.

Phase 1/2 Clinical Study Now Underway; Salarius Targeting Key Safety and Efficacy Data Milestones in 2020

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that the company will be participating in the upcoming 38th Annual JP Morgan Healthcare Conference in San Francisco.

Entries for the prize can be submitted through December 15, 2020, via an online submission portal on EasyChair.org using the link “OFP 2020.”